Clinical comparison of Provisc and Healon in cataract surgery.
This prospective, randomized, multicenter clinical trial compared the safety and efficacy of the Provisc and Healon viscoelastics. Sixty-one eyes of 61 patients had an extracapsular cataract extraction with implantation of a posterior chamber intraocular lens with the aid of Provisc (n = 32) or Healon (n = 29). Mean changes in preoperative versus postoperative corneal thickness and intraocular pressure and the incidence and magnitude of postoperative corneal edema and iritis were not significantly different between the two groups. Observed complications were considered consequences of the surgery and unrelated to viscoelastic use. No adverse medical events occurred. These results indicate Provisc and Healon are clinically equivalent in terms of safety and efficacy when used as surgical aids.
D002387:Cataract Extraction; D003315:Cornea / Q000187:drug effects; D015715:Corneal Edema / Q000209:etiology; D004548:Elasticity; D004728:Endothelium, Corneal / Q000187:drug effects; D005260:Female; D006801:Humans; D006820:Hyaluronic Acid / Q000009:adverse effects / Q000627:therapeutic use*; D007429:Intraocular Pressure / Q000187:drug effects; D007500:Iritis / Q000209:etiology; D007903:Lens Capsule, Crystalline / Q000187:drug effects; D008297:Male; D011183:Postoperative Complications; D011446:Prospective Studies; D014783:Viscosity
D006820:Hyaluronic Acid